Dermira Inc buy melinda
Start price
06.12.17
/
50%
€21.95
Target price
29.12.17
€26.61
Performance (%)
14.95%
End price
29.12.17
€25.24
Summary
This prediction ended on 29.12.17 with a price of €25.24. The prediction had a final performance of 14.95%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermira Inc | - | - | - | - |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% | 64.713% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% | 88.244% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% | 79.311% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% | 69.603% |
Comments by melinda for this prediction
In the thread Dermira Inc diskutieren
Olasacostat glasarétil (DRM01) Akne
Abgeschlossene Phase - 3 - Zulassungs kündigte am 5. Oktober 2017. Die Daten werden im ersten Quartal 2018 erhalten.
(Vom Mitglied beendet)